Initial Testing (Stage 1) of the Anti-Microtubule Agents Cabazitaxel and Docetaxel, by the Pediatric Preclinical Testing Program

BACKGROUND: While microtubule destabilizing agents (principally vincristine) are in common use in pediatric oncology, the microtubule stabilizing taxanes are uncommonly used to treat childhood cancers. Cabazitaxel has been reported to have activity superior to that of docetaxel in preclinical models...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Reynolds, C. Patrick, Kang, Min H., Maris, John M., Kolb, E. Anders, Gorlick, Richard, Wu, Jianrong, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758191/
https://ncbi.nlm.nih.gov/pubmed/26154614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25611
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados